HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong
· Delayed Price · Currency is HKD 3.030
+0.380 (14.34%)
At close: Mar 10, 2026
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.73 billion as of March 10, 2026. Its market cap has increased by 194.99% in one year.
Market Cap
1.73B
Enterprise Value
1.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.03
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.73B, a decrease of -72.84%. That is a compound annual growth rate of -44.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.51B | -10.17% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.37B |
| CANbridge Pharmaceuticals | 1.39B |
| Kintor Pharmaceutical | 1.44B |
| Immunotech Biopharm | 1.45B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| Mabpharm | 1.69B |
| Wuhan YZY Biopharma | 1.10B |
| Cutia Therapeutics | 1.71B |